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First published October 1, 2014; doi:10.1152/ajpregu.00237.2014.—The
caudal nucleus tractus solitarii (NTS) is the main central station of
cough-related afferents and a strategic site for the modulation of the
cough reflex. The similarities between the characteristics of central
processing of nociceptive and cough-related inputs led us to hypoth-
esize that galanin, a neuropeptide implicated in the control of pain,
could also be involved in the regulation of the cough reflex at the level
of the NTS, where galanin receptors have been found. We investi-
gated the effects of galanin and galnon, a nonpeptide agonist at
galanin receptors, on cough responses to mechanical and chemical
(citric acid) stimulation of the tracheobronchial tree. Drugs were
microinjected (30–50 nl) into the caudal NTS of pentobarbital sodi-
um-anesthetized, spontaneously breathing rabbits. Galnon antitussive
effects on cough responses to the mechanical stimulation of the
airway mucosa via a custom-built device were also investigated.
Bilateral microinjections of 1 mM galanin markedly decreased cough
number, peak abdominal activity, and increased cough-related total
cycle duration. Bilateral microinjections of 1 mM galnon induced
mild depressant effects on cough, whereas bilateral microinjections of
10 mM galnon caused marked antitussive effects consistent with those
produced by galanin. Galnon effects were confirmed by using the
cough-inducing device. The results indicate that galanin receptors
play a role in the inhibitory control of the cough reflex at the level of
the caudal NTS and provide hints for the development of novel
antitussive strategies.
airway defensive reflexes; galanin; galanin receptors; galnon; nucleus
tractus solitarii
COUGH IS A VERY IMPORTANT airway protective reflex and is one
of the most common reason why patients seek medical atten-
tion. Cough is purposeful and useful under many circum-
stances, but in case of persistent or chronic cough (e.g., 15) is
without an apparent aim and benefit and can results in a wide
range of physical and psychological complications including
urinary incontinence, insomnia, depression, and anxiety. The
efficacy of antitussive drugs is far from clear from the available
evidence and, in addition, limited by important side effects.
Therefore, further research to find better antitussive approaches
is necessary (for reviews see Refs. 4 and 15). Studies under-
taken to provide insights into the neural mechanisms subserv-
ing the cough reflex may also provide useful suggestions for
novel antitussive therapeutic strategies. The cough reflex in-
volves several brain stem structures that also underlie respira-
tory rhythm generation (e.g., 7, 9, 10, 19, 24, 27, 47–49, 55).
In particular, the nucleus tractus solitarii (NTS), especially in
its caudal aspects, is the main central terminus of cough-related
afferents (14, 39–41, 43, 53 also for further references) and, in
addition, a possible strategic site of synaptic plasticity, where
cough-related sensory inputs can be modulated (e.g., 10, 14,
34, 39, 40, 43).
In recent years, we and other researchers have focused our
attention on the similarities between the mechanisms underly-
ing the cough reflex and those involved in nociception and pain
sensation. Peripheral and central mechanisms of nociception
and cough share similar features, such as the type of afferent
fibers (A and C), transient receptor potential vanilloid 1 and
transient receptor potential ankyrin 1 channels, central and
peripheral sensitization, as well as the involvement of mitogen-
activated protein kinase (MAPK) signal transduction pathways
(4, 11, 12, 14, 20, 29, 40). This correspondence between
nociception and cough has led to investigations on the antitus-
sive effects of agents known to be involved in the central
control of pain sensation (4, 15).
Galanin is a 29 amino acid neuropeptide (30 amino acids in
humans) widely distributed in the central nervous system (e.g.,
21, 28, 36, 37, 63, 65) involved in many body functions such
as feeding behavior, learning and memory, neuroendocrine
control, mood disorders, antinociception, cardiovascular regu-
lation, and respiration (1, 6, 28, 44). In particular, galanin has
been implicated in the descending control of pain at the spinal
level as well as in its modulation at supraspinal sites probably
mainly via galanin-1 (GAL1) receptors (e.g., 2, 22, 32, 68;
reviewed in Refs. 38, 69). Interestingly, galanin and in partic-
ular GAL1 receptors have also been found (16, 36) in the NTS,
while neurons in the nodose ganglion have been reported to
express different types of galanin receptors (46, 59).
These findings prompted us to investigate the effects of
galanin and galnon, a nonpeptide agonist at galanin receptors
(52, 58), microinjected into the caudal NTS on cough re-
sponses induced by mechanical and chemical stimulation of the
tracheobronchial tree in pentobarbital sodium-anesthetized,
spontaneously breathing rabbits. In addition, we tried to vali-
date the mechanical stimulation of the tracheobronchial tree
delivered by a custom-built device instead of by the manual
procedure usually employed in our laboratory. To this purpose,
changes in device-induced cough responses following galnon
microinjections were also investigated.
MATERIALS AND METHODS
Ethical approval. All animal care and experimental procedures
were conducted in accordance with the Italian legislation and the
official regulations of the European Community Council on the use of
laboratory animals (Directive 86/609/EEC and 2010/63/UE). The
study was approved by the Animal Care and Use Committee of the
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University of Florence. All efforts were made to minimize both the
number of animals used and their suffering. Experimental procedures
and details about the methods employed have previously been de-
scribed (8, 9, 13, 14, 39–43).
Animal preparation. Experiments were performed on 30 male New
Zealand White rabbits (2.8–3.5 kg) anesthetized with pentobarbital
sodium (40 mg/kg iv, supplemented by 2–4 mg/kg every 30 min;
Sigma-Aldrich, St. Louis, MO). Atropine (0.15 mg/kg im) was ad-
ministered to reduce mucosal secretion in the airways. The adequacy
of anesthesia was assessed by the absence of reflex withdrawal of the
hindlimb in response to noxious pinching of the hindpaw. Additional
criteria were the presence of a stable and regular pattern of phrenic
bursts and the absence of fluctuations in arterial blood pressure or
phrenic nerve activity, whether spontaneous or in response to somatic
nociceptive stimulation.
The trachea was cannulated and polyethylene catheters were in-
serted into a femoral artery and vein for monitoring arterial blood
pressure and for drug delivery, respectively. The C3 or C5 phrenic root
on one side was prepared for recordings. The animal was placed in a
prone position and fixed by a stereotaxic head holder and vertebral
clamps; the head was ventroflexed for optimal exposure of the dorsal
surface of the medulla by occipital craniotomy. Body temperature was
maintained at 38.5–39°C by a heating blanket controlled by a rectal
thermistor probe.
Recording procedures. Bipolar platinum electrodes were used to
record efferent phrenic nerve activity from the central stump of one
cut and desheathed C3 or C5 phrenic root. Wire electrodes (Nichrome
wires, insulated except for 1 mm at the tips, diameter 0.1 mm) were
inserted into the external or the internal oblique abdominal muscles to
record electromyographic (EMG) activity. Phrenic and abdominal
activities were amplified, full-wave rectified, and “integrated” (low-
pass RC filter, time constant 100 ms). Arterial blood pressure was
recorded by a strain-gauge manometer. End-tidal CO2 partial pressure
was measured by an infrared CO2 analyzer (Capnocheck Plus, Smiths
Medical PM, Waukesha, WI). Integrated phrenic and abdominal
activities as well as the signals of the other variables were recorded on
an eight-channel rectilinearly writing chart recorder (model 8K20;
NEC San-ei, Tokyo, Japan). Cardiorespiratory variables were also
acquired and analyzed using a personal computer, equipped with an
analog-to-digital interface (Digidata 1440, Molecular Devices, Sunny-
vale, CA) and appropriate software (Axoscope, Molecular Devices).
Microinjection procedures. As fully illustrated in our previous
studies (see e.g., 14, 40, 41, 43), bilateral microinjections were
performed at two different sites along the rostrocaudal extent of the
caudal NTS and particularly into the lateral commissural NTS. The
first was at the level of the caudal-most end of the area postrema,
0.6–0.8 mm lateral to the midline, and 0.7–0.8 mm below the dorsal
medullary surface. The second was 0.5 mm more caudal, 0.4–0.5 mm
lateral to the midline, and 0.7–0.8 mm below the dorsal medullary
surface. The stereotaxic coordinates were selected according to the
atlas of Meessen and Olszewski (35). These procedures were followed
to affect as much as possible areas known to contain cough-related
second-order neurons. For details on the localization of these neurons
in the caudal NTS see Mutolo et al. (40, 41, 43) and Cinelli et al. (14).
Microinjections were performed as described in our previous re-
ports via a glass micropipette (tip diameter 10–25 m) by applying
pressure using an air-filled syringe connected to the micropipette by
polyethylene tubing. The injected volume by each microinjection was
30–50 nl. The drugs used were the following: galanin (1 mM; Tocris
Bioscience, Bristol, UK) and galnon (1 and 10 mM; Tocris Biosci-
ence), a nonpeptide agonist at galanin receptors. Galnon was also
employed at 10 mM concentration because of its much lower affinity
for galanin receptors shown by binding studies and inhibition of
adenylate cyclase activity (51, 52). Only one of these drugs was tested
in each preparation unless otherwise stated. Microinjections of galanin
and galnon with similar concentrations have been performed in
previous studies in in vivo preparations (1, 25, 52, 62, 68). Galanin
was dissolved in 0.9% NaCl solution. Galnon was initially dissolved
in 100% DMSO (Sigma-Aldrich) and then diluted in 0.9% NaCl
solution at the desired concentrations. In the final solution, the
concentration of DMSO was no more than 20%. Control injections of
equal volumes of both types of vehicle solution at the responsive sites
were also made. The localization of injection sites is diagrammatically
illustrated in Fig. 1.
Stimulation procedures. Mechanical stimulation was performed by
means of a 0.5-mm diameter nylon fiber with a smoothed tip inserted
through a lateral port of the tracheal cannula until the tip was judged
to be near the carina and main bronchi (for further details see Refs. 9,
13, 14, 39, 40, 42, 43). Forth and back movements of the fiber tip (3
cm from the lower edge of the tracheal cannula) aimed at touching
repeatedly (1 time every second) the carina or nearby airway walls
were made over periods of 4–5 s. The maneuver usually produced a
Fig. 1. Localization of injection sites. A: a diagrammatic representation of a dorsal view of the medulla oblongata of the rabbit showing where multiple bilateral
microinjections () of galanin or galnon have been performed into the caudal part of the nucleus tractus solitarii (NTS). The region of drug injections into the
caudal ventral respiratory group (cVRG) has been also indicated (shaded area). AP, area postrema; DRG, dorsal respiratory group. B: diagram of a coronal section
of the medulla oblongata at the level indicated in A (dashed line) showing the location of representative sites where the microinjections have been performed.
To simplify the presentation of results, only the distribution of sites where 1 mM galanin (Œ) was injected has been reported. The diagram also shows the location
of injection sites () into some control regions where galanin or galnon did not cause appreciable changes in the pattern of breathing and cough responses.
Representative sites of control drug microinjections at a location 0.8 mm caudal to the responsive sites of the cNTS have not been illustrated. NAC, nucleus
ambiguus caudalis; NCM, nucleus cuneatus medialis; NDV, nucleus dorsalis nervi vagi; NG, nucleus gracilis; NOI, nucleus olivaris inferior; NV, nucleus tractus
spinalis nervi trigemini; NXII; nucleus nervi hypoglossi; P, tractus piramidalis.
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bout of 2–5 coughs and was always conducted by the same experi-
menter to ensure consistency of stimulation intensity and frequency
between trials. The stimulation protocol comprised three stimulation
trials performed in succession before drug administration, repeated
5 min after the completion of all the microinjections, and at
appropriate intervals (at least 5 min) until complete recovery was
observed. An interval of 1 min was scheduled between cough
stimulations.
To standardize mechanical stimulation of the tracheobronchial tree
and to render it objective and therefore more reliable, in nine exper-
iments a custom-built device was used following the same stimulation
protocol and an attempt was made to validate this new cough-inducing
procedure. We used a nylon fiber as described above. The external end
of the fiber was connected to the noncaptive shaft of a small stepper
motor 36000 series linear actuator (Haydon Kerk Motion Solutions,
Waterbury, CT). A personal computer connected to a data acquisition
board (NI USB-6009, National Instruments Italy Srl, Assago, MI,
Italy) and equipped with an appropriate software (LabVIEW 8,
National Instruments Italy Srl) was used to drive the stepper motor
actuator. When actuated, the motor moved the fiber backward and
forward rubbing the smoothed tip onto the airway mucosa. The tip of
the fiber was positioned into the trachea just behind the point where its
further movement forward caused a cough. The characteristics of the
software allowed to set the number of forth and back movements or
cycles (1–3), shaft velocity (10–20 mm/s), and shaft displacement
(10–20 mm). The relatively slow speed of the fiber tip due to the
characteristics of the stepper motor probably implied a more lasting
contact of the fiber with the mucosa compared with manual stimula-
tion, and therefore a larger recruitment of cough receptors. After
preliminary trials, the mechanical stimulation was adjusted to the
following parameters: 1 cycle, 15 mm/s velocity, and 15 mm displace-
ment. These parameters proved to produce a bout of 2–4 coughs. An
electrical signal from the device allowed identification of the stimulus
onset.
Chemical stimulation of the tracheobronchial tree was performed
by means of citric acid inhalation (13, 14, 40, 41). Citric acid (1 M,
Sigma-Aldrich) was freshly dissolved in 0.9% NaCl solution and
nebulized (particle diameter 80% from 0.5 to 8 m; nebulization rate
0.5 ml/min) via an ultrasonic nebulizer (Projet, Artsana, Grandate,
CO, Italy). The opening of the tracheal cannula, through which the
rabbits were spontaneously breathing, was exposed to a steady stream
of the nebulized citric acid solution for3 s. This short period as well
as time intervals between chemical challenges 10 min (usually 15
min) proved to be adequate to avoid tachyphylaxis (41). Chemical
stimulation was always applied 2–3 min after mechanically induced
cough and caused a bout of several coughs usually immediately
followed by a tachypneic response (41). As a rule, chemical stimula-
tion was performed both before and 15 min after the completion of
the injections and repeated at appropriate intervals to follow the time
course of the recovery process. All stimulation procedures were
performed at least 5–6 min after each supplemental dose of pento-
barbital to avoid the possible immediate influence of the injected
bolus on both the breathing pattern and reflex responses.
Histology. At the end of each experiment, the brain was perfused
via a carotid artery with 0.9% NaCl solution and subsequently with
10% Formalin solution. After at least a 48-h immersion in 10%
Formalin solution, the brain was placed in a hypertonic sucrose
solution. Frozen 20-m coronal sections stained with cresyl violet
were used for the histological control of pipette tracks and injection
sites. The atlas of Meessen and Olszewski (35) and the more recent
atlas of Shek et al. (56) were used for comparison. Details on the
localization of injection sites and pipette tracks have already been
described in several previous reports (14, 40, 41, 43).
Data collection and analysis. Respiratory variables were measured
during eupneic breathing and reflex responses. The inspiratory (TI)
and expiratory (TE) times, as well as the total duration of the
respiratory or cough cycle (TT), were measured on recordings of raw
phrenic nerve activity. The respiratory frequency was subsequently
calculated (breaths/min). TT was measured from the onset of phrenic
nerve activity to the onset of the next phrenic burst. TI was defined as
the period from the onset of phrenic nerve activity until its maximum,
while TE was defined as the interval from the peak of phrenic nerve
activity to the onset of the next phrenic burst (e.g., 49). Peak
amplitude (arbitrary units) of the phrenic nerve activity and abdominal
EMG activity were measured on integrated traces. Normalization of
the amplitudes of phrenic and abdominal activities was performed by
expressing them as a fraction (or percentage) of the highest achievable
amplitude observed in each animal. The highest peak values were
consistently observed during coughing. Therefore, all amplitudes have
been expressed as in our previous reports in relative units (RU).
Breathing pattern variables were measured for an average of five
consecutive breaths before and after drug bilateral microinjections
into the caudal NTS. Furthermore, systolic and diastolic blood pres-
sures were measured at 2-s intervals, and mean arterial pressure was
calculated as the diastolic pressure plus one-third of the pulse pres-
sure. The measurement periods were the same selected for cough-
related variables (see below). Owing to the small variations in respi-
ratory and cardiovascular variables within each measurement period,
average values were taken as single measurements for the purpose of
analysis.
The cough motor pattern in response to mechanical or chemical
stimulation of the tracheobronchial tree is characterized by repeated
coughs. Each of them consists of an augmented phrenic burst (prepa-
ratory inspiration) immediately followed by a burst of expiratory
abdominal activity (9, 13, 14, 39–43). In agreement with our previous
results, repeated coughs usually started during stimulation and con-
tinued shortly after stimulus cessation. Respiratory variables of
coughs (cough-related variables) included the cough-related TT, TI,
and TE, peak phrenic amplitude (RU), peak abdominal activity (RU),
and the cough number, i.e., the number of coughs following each
stimulation. Cough-related variables were measured and averaged
before and after drug administration at the time when the maximum
response occurred as well as at the time when a complete recovery
was observed (three trials for mechanical stimulation and a single trial
for citric acid inhalation). The average values of cough-related vari-
ables were taken as single measurements for subsequent statistical
analysis (Sigma Stat, SPSS, Chicago, IL). In some cases, the first
obvious response following mechanical stimulation of the tracheo-
bronchial tree was a small-amplitude expiratory effort without a
preceding preparatory inspiration. This pattern could fit more appro-
priately the definition of expiration reflex that is typically evoked by
mechanical stimulation of the vocal folds, but that can be also
produced by mechanical stimulation of the tracheobronchial tree (26,
64). For further details see Mutolo et al. (39–43) and Cinelli et al. (13,
14). However, in our study an expiration reflex only occurred as the
first motor event in a cough epoch, and its appearance was limited to
a few occasions. Therefore, these expiratory responses were not
considered for data analysis.
Average values of cough-related variables observed under control
conditions at the time when the maximum response to drug microin-
jections occurred and after complete recovery were used for statistical
analysis. Average values of baseline cardiorespiratory variables dur-
ing the same periods were also considered. Comparisons were per-
formed by means of the one-way repeated-measures ANOVA fol-
lowed by Student-Newman-Keuls tests. To validate the reliability of
the cough-inducing device, cough responses at 30-min intervals were
compared by the same statistical analysis. All reported values are
means  SE; P  0.05 was taken as significant.
RESULTS
Galanin-induced effects. Bilateral microinjections of 1 mM
galanin (30–50 nl; 30–50 pmol) into the caudal NTS were
performed in four animals. They induced within 15 min
R1360 COUGH DOWNREGULATION BY GALANIN RECEPTORS
AJP-Regul Integr Comp Physiol • doi:10.1152/ajpregu.00237.2014 • www.ajpregu.org
(maximum effect) consistent and marked reductions in the
cough response to both mechanical and chemical stimulation of
the tracheobronchial tree (Table 1 and Fig. 2A). The cough
number and peak abdominal activity decreased, whereas the
cough-related TT increased due to a rise in both TI and TE.
Cough-depressant effects developed progressively, but they
were already clearly appreciable on mechanically induced
cough within 5 min after the microinjections. The complete
recovery of the cough reflex was seen after 60–90 min from the
completion of the microinjections. The time course of galanin
effects on the cough number in cough bouts induced by both
mechanical and chemical stimulations of the tracheobronchial
tree is reported in Fig. 2B.
Galnon-induced effects. Bilateral microinjections of 1 mM
galnon (30–50 nl; 30–50 pmol) into the caudal NTS performed
in four animals induced mild suppressant effects on the cough
reflex. About 10 min after the injections (maximum effect),
decreases only in the cough number and in the peak abdominal
activity were observed. The cough number decreased from
3.7  0.14 to 2.7  0.25 (P  0.05) during mechanical
stimulation and from 5.0  0.91 to 4.3  0.81 (P  0.05)
during chemical stimulation. Peak abdominal activity changed
from 0.60  0.03 to 0.42  0.02 RU (P  0.05) and from
0.54  0.01 to 0.44  0.02 RU (P  0.05) during mechanical
and chemical stimulation, respectively. The recovery of these
variables occurred within 40 min.
Bilateral microinjections of 10 mM galnon (30–50 nl; 300–
500 pmol) into the caudal NTS of five rabbits caused within
15 min (maximum effect) marked decreases in cough re-
sponses (Table 1 and Fig. 3). The cough number and peak
abdominal activity decreased, whereas the cough-related TT
increased as a consequence of increases in both TI and TE.
Galnon turned out to induce changes in cough-related variables
consistent with those caused by galanin. Also galnon-induced
effects developed gradually, but they were already evident
within 5 min after the microinjections. The recovery was
complete within 60–90 min.
Galnon-induced effects on device-induced cough responses.
In a series of nine experiments, cough reflex responses were
induced by the custom-built device. In four animals, cough-
related variables were measured at different time intervals, i.e.,
at the beginning of the experiment after animal stabilization
(control) and at intervals of about 30 min. They remained very
accurately repeatable at least for 2 h. For simplicity only
control values and those recorded after 2 h have been reported
in Table 2. Thereafter, within a variable time period ranging
from 30 to 60 min, cough responses resulted altered in three of
four animals, possibly due to mucus production and to some
time-dependent deterioration of the airway mucosa.
In five preparations, changes in cough responses following
microinjections of 10 mM galnon into the caudal NTS were
investigated. Galnon-induced effects (Table 2 and Fig. 4)
consisted of decreases in the cough number and peak abdom-
inal activity associated with increases in the cough-related TT
due to a rise in both TI and TE. The recovery was complete
within 60–90 min. Noticeably, these effects were consistent
with those induced by 10 mM galnon on cough responses to
mechanical stimulation executed manually (see Table 1 and 2).
Drug treatment and cardiorespiratory variables during eu-
pneic breathing. Bilateral microinjections of galanin or galnon
into the caudal NTS did not affect cardiorespiratory variables
during eupneic control breathing (see e.g., control recordings
before reflex responses in Figs. 2, 3, and 4; statistical data not
shown). However, we observed that following microinjections
of both galanin and galnon, basal abdominal activity was
greatly reduced without concomitant changes in phrenic bursts.
Abdominal activity decreased from 0.06  0.005 to 0.02 
0.01 RU (P  0.05) after 1 mM galanin (n  4) and from
0.05  0.006 to 0.03  0.002 RU (P  0.05) after 10 mM
galnon (n  5). The recovery of abdominal activity paralleled
the recovery of cough-related variables. Mean arterial blood
pressure was maintained between 96 and 104 mmHg. For a
general evaluation of cardiorespiratory variables in the rabbit
under control conditions, see also previous reports (39, 41, 43).
Table 1. Cough-related variables before and 15 min after bilateral microinjections of galanin and galnon into the caudal
NTS
CN TT, s TI, s TE, s PPA, RU PAA, RU
Galanin (n  4)
Mechanical stimulation
Control 3.5  0.28 0.59  0.04 0.36  0.02 0.22  0.03 0.63  0.02 0.58  0.03
1 mM 1.7  0.32* 0.77  0.05* 0.44  0.02* 0.32  0.04* 0.55  0.05 0.37  0.06*
Recovery 3.4  0.26 0.60  0.05 0.37  0.03 0.22  0.04 0.64  0.03 0.57  0.03
Citric acid inhalation
Control 5.7  0.94 0.49  0.04 0.31  0.02 0.17  0.02 0.61  0.02 0.58  0.03
1 mM 4.0  0.70* 0.65  0.03* 0.37  0.01* 0.27  0.03* 0.58  0.02 0.29  0.05*
Recovery 5.6  0.92 0.48  0.03 0.31  0.03 0.16  0.02 0.60  0.01 0.58  0.04
Galnon (n  5)
Mechanical stimulation
Control 3.7  0.27 0.58  0.03 0.34  0.04 0.23  0.03 0.64  0.02 0.59  0.06
10 mM 1.8  0.24* 0.78  0.06* 0.42  0.02* 0.35  0.04* 0.55  0.06 0.40  0.07*
Recovery 3.5  0.25 0.59  0.03 0.34  0.03 0.24  0.04 0.63  0.02 0.57  0.06
Citric acid inhalation
Control 5.4  0.40 0.50  0.01 0.32  0.01 0.17  0.01 0.69  0.03 0.56  0.02
10 mM 3.3  0.37* 0.63  0.03* 0.37  0.02* 0.26  0.03* 0.60  0.06 0.38  0.07*
Recovery 5.3  0.39 0.49  0.01 0.31  0.01 0.18  0.02 0.67  0.03 0.54  0.02
Values are means  SE; n, number of animals. CN, cough number; TT, cycle duration; TI, inspiratory time; TE, expiratory time; PAA, peak phrenic activity
in relative units (RU); PPA, peak abdominal activity in relative units (RU). *P  0.05 compared with control cough as well as with recovery.
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Fig. 2. Depressant effects of 1 mM galanin microinjected into the selected sites of the caudal NTS on cough reflex responses elicited by mechanical stimulation
of the tracheobronchial tree and by the inhalation of 1 M citric acid in one anesthetized spontaneously breathing rabbit. A: original recordings illustrating the
reduction of cough responses 15 min after bilateral microinjections of galanin when the maximum effect occurred. Recovery of cough responses was taken
90 min after the injections. Stimulation periods marked by filled bars. Phr IN, phrenic integrated neurogram; Phr N, phrenic neurogram; Abd IEMG, abdominal
integrated electromyographic activity; Abd EMG, abdominal electromyographic activity. B: time courses of galanin effects on the cough number. Galanin
microinjections indicated by the arrow. Ctr, control. *P  0.05 compared with control.
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Controls. In eight additional preparations, bilateral control
microinjections of 1 mM galanin (4 animals) and 10 mM
galnon (4 animals) were performed at different medullary
locations sufficiently far from the responsive sites (14, 39–41,
43, 45, 60). Four microinjections of each drug were executed
[for comparison, see Meessen and Olszewski (35) and Shek et
al. (56)] into the nucleus cuneatus medialis, the nucleus tractus
spinalis nervi trigemini, and at a location 0.8 mm caudal to
the responsive sites of the caudal NTS. Similarly, in all these
additional preparations control microinjections of galanin (4
animals) and galnon (4 animals) were performed into the
caudal ventral respiratory group at sites defined in previous
reports by stereotaxic coordinates derived from prior extracel-
lular recordings from expiratory neurons (13, 14, 41, 42). In all
instances, no appreciable changes in the pattern of breathing
and cough responses were observed. In particular, it is worth
noting that galanin and galnon did not cause any significant
effect on the cough reflex when microinjected into the caudal
ventral respiratory group, a widely recognized site of action of
centrally acting antitussive drugs and a neural structure with a
prominent role in the regulation of the cough reflex (see e.g., 9,
13, 14, 41, 42, 48, 50).
Control bilateral microinjections of each type of vehicle
solution at the responsive sites were performed in some prep-
arations before the administration of galanin (3 trials) or galnon
(3 trials). In addition, control bilateral microinjections of either
saline or DMSO solution at the responsive sites were also
performed in two of the eight additional preparations. In
accordance with the results of our previous studies (39, 40, 43),
these control injections did not significantly affect cough reflex
responses. The localization of the injection sites was confirmed
by the histological control (for details see Refs. 14, 40, 41, 43).
Figure 1 illustrates the localization of injection sites on a dorsal
view of the medulla oblongata as well as the distribution of
injection sites within the caudal NTS and within some of the
control regions. For simplicity, only the distribution of sites
where 1 mM galanin was injected has been reported.
DISCUSSION
In this study we provide for the first time evidence that
galanin and the nonpeptide galanin receptor agonist galnon
microinjected into the caudal NTS cause depressant effects on
cough responses induced either by mechanical stimulation of
the tracheobronchial tree or by citric acid inhalation in the
anesthetized rabbit. Present findings support the notion that the
caudal NTS is an important site for the inhibitory modulation
of the cough reflex and indicate that galanin receptors play an
important role in this function. At variance with other antitus-
sive agents (9, 13, 14, 41, 42, 50), galanin does not appear to
be involved in the central regulation of cough at the level of the
caudal ventral respiratory group. These results provide further
evidence supporting the similarities between the characteristics
of central processing of nociceptive and cough-related inputs.
Device-induced cough responses appear to be fairly repeatable
Fig. 3. Depressant effects of 10 mM galnon microinjected into the caudal NTS on cough reflex responses induced by mechanical stimulation of the
tracheobronchial tree and by the inhalation of 1 M citric acid in one anesthetized spontaneously breathing rabbit. Depression of cough responses 15 min after
bilateral microinjections when the maximum effect occurred. Recovery of cough responses was taken 90 min after the injections. Stimulation periods marked
by filled bars.
Table 2. Cough-related variables during device-induced mechanical stimulation of the tracheobronchial tree in control
conditions as well as before and 15 min after 10 mM galnon bilateral microinjections into the caudal NTS
CN TT, s TI, s TE, s PPA, RU PAA, RU
Control conditions (n  4)
Control 3.0  0.24 0.51  0.03 0.35  0.01 0.16  0.01 0.62  0.01 0.52  0.03
2 h later 2.9  0.25 0.52  0.02 0.36  0.01 0.17  0.02 0.61  0.02 0.51  0.04
Galnon (n  5)
Control 3.0  0.32 0.54  0.02 0.34  0.01 0.19  0.03 0.62  0.03 0.52  0.04
10 mM 1.7  0.13* 0.77  0.06* 0.44  0.03* 0.33  0.05* 0.58  0.02 0.30  0.05*
Recovery 3.1  0.34 0.53  0.02 0.34  0.02 0.18  0.04 0.61  0.03 0.51  0.03
Values are means  SE; n, number of animals. *P  0.05 compared with control cough as well as with recovery.
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for at least 2 h and suitable to disclose drug-induced effects on
the cough reflex.
General remarks. Unfortunately, we were not able to em-
ploy galanin receptor antagonists (M40 and M871, Tocris
Bioscience) and selective agonists (M617 and ARM1896,
Tocris Bioscience) owing to their poor aqueous solubility that
did not allow us to obtain stable and reliable solutions at final
millimolar concentrations and, as far as the antagonists are
concerned, even at concentrations 0.5 mM. Relatively high
drug concentrations (mM) have been shown to be as a rule
necessary for microinjection techniques, as fully discussed in a
previous report (8). The reliability of microinjection techniques
and the characteristics of the spread of the injectate have been
discussed in detail in previous studies (9, 13, 14, 39–43).
However, for a more exhaustive appraisal and discussion on
drug diffusion following microinjections into the central ner-
vous system as well as on their reliability see Refs 18, 31, 45,
and 60. The specificity of drug-induced effects is supported by
the absence of changes in cough-reflex responses following
bilateral microinjections of vehicle solutions into the caudal
NTS or drug microinjections into regions sufficiently away
from the responsive sites. In the present study, no significant
effects on the eupneic pattern of breathing were induced by
galanin or galnon microinjections into the caudal NTS except
for a selective depression in basal abdominal activity. Interest-
ingly, changes in mean arterial blood pressure that may affect
the intensity of the cough reflex (49) were not seen. These
findings reveal decreased motoneuron excitability, a phenom-
enon that could underlie changes in cough-related variables
and especially decreases in peak abdominal activity (for a
review, see Ref. 53) and imply a specific action of the em-
ployed drugs on central cough-related pathways within the
NTS (see also below).
Changes in cough-related variables. Interestingly, changes
in cough-related variables induced by galanin or galnon mi-
croinjections into the caudal NTS (Tables 1 and 2) recall those
previously observed following microinjections of low concen-
trations of [D-Ala2,N-Me-Phe4,Gly5-ol]-enkephalin (DAMGO), a
-opioid agonist, baclofen, a GABAB receptor agonist, and
clonidine, an 	2-adrenergic receptor agonist, into the same
medullary region (14, 39). As in these previous reports, both
galanin and galnon increased the cough-related TT because of
increases in TI and TE. In addition, the absence of changes in
peak phrenic amplitude associated with an increase in TI
indicates depressant effects on inspiratory activity and inspira-
tory drive revealed by the reduced rate of rise of inspiration
Fig. 4. Downregulation of the cough reflex responses to device-induced mechanical stimulation of the tracheobronchial tree following bilateral microinjections
of 10 mM galnon into the caudal NTS in one anesthetized spontaneously breathing rabbit. Reduction of the cough reflex 15 min after the completion of the
injections. The complete recovery of cough reflex was obtained 90 min after the injections. The onset of mechanical stimulation is indicated by arrows.
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(61). Noticeably, increases in the cough-related TE were also
observed after N-methyl-D-aspartate (NMDA) receptor block-
ades within the caudal NTS (41, 43). On the basis of the
differential effects of antitussive drugs on the cough and
breathing pattern, Bolser and colleagues (7, 50) have proposed
the presence of a cough-gating mechanism controlling inspira-
tory and expiratory burst amplitude as well as cough number,
but not phase duration. Present and previous results from our
laboratory (e.g., 13, 14, 39–43) are, at least in part, consistent
with this view. However, as already mentioned, we have
observed not only changes in the cough number, but also in the
time components of the cough reflex. In agreement with our
previous interpretation, this discrepancy can be tentatively
attributed to differences in the animal species, experimental
conditions, and characteristics of the employed drugs.
Role of galanin receptors. There are three types of galanin
receptors, GAL1, GAL2, and GAL3, and all these are G
protein-coupled receptors (28, 63). GAL1 receptors are the
most abundant and widely expressed at least in the central
nervous system of adult rats (28, 30, 63 also for further
references). In particular, GAL1 receptors are strongly repre-
sented in the pons-medulla oblongata and in dorsal spinal cord
regions. GAL2 receptors are also broadly expressed in the
central nervous system, but in regions less relevant to cough
regulation such as the hippocampus, the hypothalamus, and the
spinal trigeminal tract, whereas GAL3 receptors are mainly
expressed in peripheral tissues (for a review, see Ref. 28).
Interestingly, GAL1 receptors have also been found in the NTS
(16, 36), a neural structure, as already mentioned, essential for
the genesis of cough reflex responses. Owing to the similarities
between nociception and cough-related mechanisms, a major
involvement of GAL1 receptors in the downregulation of the
cough reflex can be hypothesized. In fact, it has been reported
that GAL1 receptors probably mediate analgesic effects,
whereas GAL2 receptors are mainly involved in pro-nocicep-
tive effects (e.g. 2, 22, 32, 68; reviewed in Refs. 38, 69).
Galanin may exert its action presynaptically through both
GAL1 and GAL2 receptors as well as postsynaptically predom-
inantly via GAL1 receptors (2, 28). In this context, it should be
also recalled that galanin antagonizes substance P-evoked hy-
peralgesia (23, 70; see Ref. 69 also for further references) and
that its antinociceptive effects involve opioid receptors and
display positive interactions with NMDA receptor antagonists
(22, 25, 62, 66; see Ref. 69 also for further references). These
findings are relevant to the galanin antitussive effects since
both a protussive role of substance P (34, 43) and an antitussive
action of opioid receptor agonists and NMDA receptor antag-
onists (39, 41, 43) have been demonstrated within the caudal
NTS.
Projections of galaninergic neurons to caudal NTS neurons
may derive from several sites of the central nervous system
(see e.g., 28, 36, 37, 63). However, their antitussive role is, at
present, only matter of speculation. Galaninergic neurons pos-
sibly involved in this function could be localized in the NTS
itself or in neural structures already proved to be engaged in the
antinociceptive control, such as the medullary midline raphe
nuclei or the periaqueductal grey (e.g., 38, 62). To further
support the parallel between nociception and cough, we can
also mention that medullary raphe nuclei have a complex role
in the generation of airway defensive reflexes including cough
(e.g., 3, 24, 57) and that, in addition, suppressive influences
from the periaqueductal grey and the nucleus raphe magnus on
the cough reflex have been demonstrated (54). Interestingly,
similarly to galanin-induced antinociception, these influences
are in part mediated by opioids.
Galnon has been involved in several physiological functions
including nociception, that has been suggested to engage
mainly galanin receptors (52, 58, 67). Galnon has been re-
ported to display higher affinity for GAL1 receptors and exerts
its effects mainly through this receptor subtype (5, 33, 52).
Although galnon has also been shown to be a ligand to other G
protein-coupled receptors in addition to GAL1–3 receptors and
to activate intracellular G proteins directly (17, 51), we are
confident that its antitussive effects are mainly due to an action
on galanin receptors owing to their similarities with those
caused by galanin. In fact, as we have suggested above for
galanin-induced downregulation of the cough reflex, it seems
reasonable to propose that GAL1 receptors have a prominent
role. On the other hand, GAL1 receptors have been implicated
in the mediation of the antinociceptive and anticonvulsant
functions of galnon (52, 67). Galnon depressant effects on the
cough reflex induced by mechanical stimulation of the tracheo-
bronchial tree as well as the subsequent complete recovery of
cough responses were confirmed by using the cough-inducing
device. These outcomes appear to validate this new stimulation
procedure. In particular, the repeatability of device-induced
cough responses and the complete recovery after drug admin-
istration ensure reliability. Device-induced cough responses, as
already mentioned, were accurately repeatable for at least 2 h
in all tested preparations. After this period, despite cleaning
and repositioning of the nylon fiber, cough responses were no
more reliably comparable with those obtained before because
of consistent decreases especially in the cough number and
peak abdominal activity. Thus we took as appropriate for
cough studies a 2-h working period of the device. Post mortem
analysis of the trachea and main bronchi revealed the presence
of mucus, but no evidence of obvious mucosal lesions that,
however, could be present at the histological level given the
relatively high number of stimulation trials performed (histo-
logical analysis not performed).
Perspectives and Significance
Present results contribute to get further insights into the
central neural mechanisms involved in the control of the cough
motor pattern and especially of those operating within the
caudal NTS. They confirm that the caudal NTS is an important
neural structure where cough-related sensory inputs can be
modulated and a prominent site of action of centrally acting
antitussive drugs (e.g., 10, 14, 34, 39, 40, 43). We believe that
the present findings are of particular interest since they are the
first to provide evidence that galanin receptors are involved in
the downregulation of the cough reflex at the level of the NTS,
where galanin receptors have been found (16, 36).
In addition, present results corroborate the correlation be-
tween nociception and cough (4, 11, 12, 14, 20, 29, 40) and
support the advantage of treating chronic cough with drugs
already employed in neuropathic pain. They also encourage
further studies on galanin receptor agonists to develop novel
antitussive compounds with proved efficacy and devoid of
important side effects.
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